Search

everythinglearnresearchcommunity

for

Search:↓

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Traditional healers in Namibia use 70 different plants to treat AIDS-related diseases, and more research is needed to test these plants' effectiveness against HIV.

Annurca apple extract promotes hair growth by changing hair follicle metabolism to boost keratin production.

The conference presented findings on how vitamin D levels, genetic factors, and lifestyle choices like smoking and yoga affect various health conditions and diseases.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Annurca apple extract may protect mouse hair from damage by chemotherapy and could help treat hair loss without promoting cancer growth.

The WNT signaling pathway is important in many diseases and targeting it could offer new treatments.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Plant-based products can improve hair and skin health without harmful side effects.

Biomimetic scaffolds are better than traditional methods for growing cells and could help regenerate various tissues.

Stem cell therapies show promise for treating hair loss, but more research is needed to understand their safety and effectiveness.

The TRPV3 ion channel is important for skin and hair health and could be a target for treating skin conditions.

Microneedles are promising for long-acting drug delivery and can improve patient compliance, but more data is needed to confirm their effectiveness.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

The new "whisker follicle microinjection assay" can test how different biomolecules affect hair growth and color.

Fissistigma oldhamii has compounds that help with pain, inflammation, and other health issues.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Thyroid receptor β can help develop new drugs to treat hair loss.

The Rotterdam Study aims to understand various diseases in older adults.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

Cannabinoids may help treat various skin conditions.

Coffee berry extract may help slow skin aging and prevent hair loss.

Targeting CXXC5 and GSK-3β may help treat male pattern baldness.

Melatonin-loaded nanocarriers improve melatonin delivery and effectiveness for various medical treatments.

New treatments for enlarged prostate are being developed to be more effective and have fewer side effects.

New regenerative therapies show promise for treating hair loss.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

New microneedle treatment with growth factors and a hair loss drug shows better and faster hair growth results than current treatments.

The conclusion is that formalizing how past decisions influence current health technology assessments could improve the credibility and defense of coverage decisions.